Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Pilocarpine for Xerostomia in Life-limiting Illness or Frailty
2022-501084-41-00Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in xerostomia comparing Pilocarpine hydrochloride oral drops with Placebo oral drops (2 arms). Primary endpoint: Percentage of responders at week 4. Started Mar 2023; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on 2022-501084-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501084-41-00.